Effect of acupuncture on cardiac function and autonomic nervous system in heart failure patients

Comparing the effect of acupuncture and medication on cardiac and autonomic function in patients with heart failure

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201706087265N8

Enrollment

Registered

2017-09-22

Start date

2017-10-22

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure. Heart failure

Interventions

Intervention 1: Intervention group: 12 sessions of acupuncture (3 times per week) and medication. Intervention 2: Control group: medication.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age>= 21 Heart failure with reduced ejection fraction (LVEF =40%) New York Heart Association class II-III sinus rhythm patient consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: before study and at week 8. Method of measurement: Using sphygmomanometer.;Heart Rate. Timepoint: before study and at week 8. Method of measurement: Examination of pulse and counting the pulses per minute.;6 minute walk test. Timepoint: before study and at week 8. Method of measurement: Measuring the patient's walking distance on a specified path within 6 minutes.;PR wave. Timepoint: before study and at week 8. Method of measurement: Time distance of PR wave in electrocardiogram (seconds).;QRS wave. Timepoint: before study and at week 8. Method of measurement: Time distance of QRS wave in electrocardiogram (seconds).;Ejection Fraction. Timepoint: before study and at week 8. Method of measurement: Percentage of cardiac ejection fraction in echocardiography.;Righ ventricular end diastolic diameter. Timepoint: before study and at week 8. Method of measurement: Righ ventricular end diastolic diameter in echocardiography (cm).;Left ventricular end diastolic diameter. Timepoint: before study and at week 8. Method of measurement: left ventricular end diastolic diameter in echocardiography (cm).;Tricuspid annular plane systolic excursion. Timepoint: Before study and at week 8. Method of measurement: Measuring by echocardiography (mm).;End Systolic Volume. Timepoint: before study and at week 8. Method of measurement: End Systolic Volume in echocardiography (ml).;NYHA class. Timepoint: before study and at week 8. Method of measurement: The amount of activity that dyspnea occures according to the patient's history (a 4 points scale).	—

Measure

Time frame

Blood pressure. Timepoint: before study and at week 8. Method of measurement: Using sphygmomanometer.;Heart Rate. Timepoint: before study and at week 8. Method of measurement: Examination of pulse and counting the pulses per minute.;6 minute walk test. Timepoint: before study and at week 8. Method of measurement: Measuring the patient's walking distance on a specified path within 6 minutes.;PR wave. Timepoint: before study and at week 8. Method of measurement: Time distance of PR wave in electrocardiogram (seconds).;QRS wave. Timepoint: before study and at week 8. Method of measurement: Time distance of QRS wave in electrocardiogram (seconds).;Ejection Fraction. Timepoint: before study and at week 8. Method of measurement: Percentage of cardiac ejection fraction in echocardiography.;Righ ventricular end diastolic diameter. Timepoint: before study and at week 8. Method of measurement: Righ ventricular end diastolic diameter in echocardiography (cm).;Left ventricular end diastolic diameter. Timepoint: before study and at week 8. Method of measurement: left ventricular end diastolic diameter in echocardiography (cm).;Tricuspid annular plane systolic excursion. Timepoint: Before study and at week 8. Method of measurement: Measuring by echocardiography (mm).;End Systolic Volume. Timepoint: before study and at week 8. Method of measurement: End Systolic Volume in echocardiography (ml).;NYHA class. Timepoint: before study and at week 8. Method of measurement: The amount of activity that dyspnea occures according to the patient's history (a 4 points scale).

—

Secondary

Measure	Time frame
Quality of life. Timepoint: before study and at week 8. Method of measurement: The score of patient's quality of life according to SF36 questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farveh Vakilian

Department of Cardiology, School of Medicine, Mashhad University of Medical Sciences

vakilianf@mums.ac.ir+98 51 3854 3031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026